Cargando…
Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells
Vasculogenic mimicry (VM) is the alternative process of forming vessel-like networks by aggressive tumor cells, and it has an important role in tumor survival, growth, and metastasis. Epigallocatechin-3-gallate (EGCG) is well known to have diverse bioactivities including anti-cancer effects. However...
Autores principales: | Yeo, Changhwan, Han, Deok-Soo, Lee, Hyo-Jeong, Lee, Eun-Ok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013924/ https://www.ncbi.nlm.nih.gov/pubmed/31936664 http://dx.doi.org/10.3390/ijms21020439 |
Ejemplares similares
-
Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells
por: Han, Deok-Soo, et al.
Publicado: (2022) -
Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway
por: Xiao, Ting, et al.
Publicado: (2018) -
Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin
por: Delgado-Bellido, Daniel, et al.
Publicado: (2017) -
Endothelial Phosphatase VE-PTP Participates in Vasculogenic Mimicry by Preventing Autophagic Degradation of VE-Cadherin
por: Delgado-Bellido, Daniel, et al.
Publicado: (2020) -
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry
por: Delgado-Bellido, Daniel, et al.
Publicado: (2023)